Capital Fund Management S.A. Bridge Bio Pharma, Inc. Transaction History
Capital Fund Management S.A.
- $36 Billion
- Q3 2024
A detailed history of Capital Fund Management S.A. transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Capital Fund Management S.A. holds 20,400 shares of BBIO stock, worth $552,636. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,400Holding current value
$552,636% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding BBIO
# of Institutions
291Shares Held
171MCall Options Held
10.4MPut Options Held
2.37M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY25.3MShares$684 Million35.94% of portfolio
-
Viking Global Investors LP25.1MShares$681 Million2.47% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.2MShares$385 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$337 Million0.01% of portfolio
-
Aisling Capital Management LP New York, NY6.07MShares$164 Million63.58% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $4.02B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...